HOME >> BIOLOGY >> NEWS
Plants, plasmids and possibilities -- Methods permit functional gene studies in plants

COLD SPRING HARBOR, N.Y. (Fri., Dec. 1, 2006) -- Decaffeinated coffee plants, pest-resistant cotton, and Vitamin A-producing rice varieties have all been developed by introducing genes into plants. Scientists also create modified plants to identify and characterize the functions of specific genes. The current issue of Cold Spring Harbor Protocolsreleased online today (www.cshprotocols.org)includes a set of techniques for the creation of transgenic plants.

One of the protocols, freely available at http://www.cshprotocols.org/cgi/content/full/2006/30/pdb.prot4668, describes the use of a bacterium, Agrobacterium, to create transgenic Arabidopsis plants. Arabidopsis is used in many studies due to its short reproductive cycle, ease of cultivation, and close relatedness to economically important species such as broccoli and cauliflower. Agrobacterium contains a small chromosomecalled the Ti plasmidinto which scientists can insert a gene of interest. This transgene is transferred to Arabidopsis through natural infection with Agrobacterium.

The highlighted article from CSH Protocols describes three techniques that encourage Agrobacterium to infect Arabidopsis plants: dipping an Arabidopsis flower directly into a solution containing Agrobacterium, mechanically forcing the Agrobacterium into the plant cells by applying vacuum, and simply spraying an Agrobacterium suspension onto the plants.


'"/>

Contact: Maria A. Smit
smit@cshl.edu
516-422-4127
Cold Spring Harbor Laboratory
1-Dec-2006


Page: 1

Related biology news :

1. Plants, too, have ways to manage freeloaders
2. Plants, animals share molecular growth mechanisms
3. Potent possibilities for parasite attack
4. Heart failure: Intervention possibilities from imaging programmed cell loss
5. Research on microfluidics widens the possibilities for electronic devices
6. Poplar DNA code cracked -- new possibilities for sustainable energy
7. New possibilities to fight pests with biological means
8. New possibilities for flu antiviral and vaccine research emerge from Spanish flu virus
9. Brains opioid receptorsor endorphin systemmay hold key to treatment possibilities for bulimia
10. Alzheimers disease; new approach, new possibilities?
11. MIDI, Inc receives Official Methods(SM) status for the confirmatory ID of the anthrax pathogen

Post Your Comments:
(Date:5/22/2013)... life scientists provide important new details on how climate ... online May 21 in the Journal of Animal ... making accurate predictions and informing policymakers of how species ... , "There is a growing recognition among biologists ... one another, and that this is going to have ...
(Date:5/21/2013)... to a whale entangled in fishing gear, scientists showed ... whale,s diving and swimming behavior. The monitoring revealed how ... depletes their energy as they drag gear for months ... , The scientists in this entanglement response suction-cupped a ... North Atlantic right whale called Eg 3911. The Dtag, ...
(Date:5/21/2013)... developed a new method for delivering molecules into ... cell surface. The technique could find applications in ... , Bulk electroporation a technique used to ... the cell membrane that are caused by exposing ... popular method of cell transfection. (Cell transfection is ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Single-cell transfection tool enables added control for biological studies 2
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
(Date:5/21/2013)... new study led by George Washington University Professor ... of ice in small droplets is strongly size-dependent, ... the nanoscale. The formation of ice at the ... whose answer also has important implications for climate ... of ice from supercooled water is generally initiated ...
(Date:5/21/2013)... May 21, 2013 Smarter Security, Inc., ... solutions, today announced that Genzyme, a Sanofi company and ... Door Detective® CL for a multi-use facility in the ... four other Genzyme buildings, this latest order underscores the ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: